VANGUARD GROUP INC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$9,954,604
-24.4%
2,868,762
+1.4%
0.00%
Q2 2023$13,159,072
+2.6%
2,829,908
+1.9%
0.00%
Q1 2023$12,829,564
-40.0%
2,776,962
+5.0%
0.00%
-100.0%
Q4 2022$21,368,950
+87.8%
2,644,672
+29.0%
0.00%
Q3 2022$11,379,000
+7.2%
2,050,276
+0.6%
0.00%
Q2 2022$10,614,000
-42.1%
2,037,325
-8.7%
0.00%
Q1 2022$18,338,000
-41.8%
2,230,997
+5.3%
0.00%
-100.0%
Q4 2021$31,513,000
-21.1%
2,117,807
+0.1%
0.00%0.0%
Q3 2021$39,952,000
+4.2%
2,115,031
+2.5%
0.00%0.0%
Q2 2021$38,355,000
-17.4%
2,063,195
+1.1%
0.00%0.0%
Q1 2021$46,431,000
+11.2%
2,039,989
+6.0%
0.00%0.0%
Q4 2020$41,761,000
+219.7%
1,923,619
+48.0%
0.00%
Q3 2020$13,064,000
+68.5%
1,299,805
+30.1%
0.00%
Q2 2020$7,753,000
+101.0%
998,965
+164.2%
0.00%
Q1 2020$3,857,000
+3.0%
378,178
+11.0%
0.00%
Q4 2019$3,746,000
+27.5%
340,587
+5.3%
0.00%
Q3 2019$2,939,000
+32.3%
323,299
+65.6%
0.00%
Q2 2019$2,222,000
+10.4%
195,254
+10.5%
0.00%
Q1 2019$2,013,000
+79.6%
176,772
+42.2%
0.00%
Q4 2018$1,121,000124,2830.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders